Details for New Drug Application (NDA): 064093
✉ Email this page to a colleague
NDA 064093 describes GENTAMICIN SULFATE, which is a drug marketed by Alpharma Us Pharms, Cosette, Fougera Pharms Inc, Padagis Us, Pharmaderm, Taro, Abbott, Eugia Pharma, Fresenius Kabi Usa, Hikma, Hospira, Kalapharm, Pharm Spec, Solopak, Teva Parenteral, Watson Labs, Wyeth Ayerst, Fera Pharms Llc, Sciegen Pharms Inc, Encube, Alcon Pharms Ltd, Bausch And Lomb, Epic Pharma Llc, Paco, Sandoz, B Braun, and Baxter Hlthcare, and is included in forty NDAs. It is available from twenty-three suppliers. Additional details are available on the GENTAMICIN SULFATE profile page.
The generic ingredient in GENTAMICIN SULFATE is gentamicin sulfate. There are fifteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
The generic ingredient in GENTAMICIN SULFATE is gentamicin sulfate. There are fifteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
Summary for 064093
| Tradename: | GENTAMICIN SULFATE |
| Applicant: | Sciegen Pharms Inc |
| Ingredient: | gentamicin sulfate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 064093
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| GENTAMICIN SULFATE | gentamicin sulfate | OINTMENT;OPHTHALMIC | 064093 | ANDA | Proficient Rx LP | 63187-873 | 63187-873-35 | 1 TUBE in 1 CARTON (63187-873-35) / 3.5 g in 1 TUBE |
| GENTAMICIN SULFATE | gentamicin sulfate | OINTMENT;OPHTHALMIC | 064093 | ANDA | Redpharm Drug | 67296-0114 | 67296-0114-1 | 1 TUBE in 1 CARTON (67296-0114-1) / 3.5 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | EQ 0.3% BASE | ||||
| Approval Date: | Aug 31, 1995 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
